Title:
Phase II trial for the treatment of older patients with newly diagnosed CD19 positive, Ph/BCR-ABL negative B-precursor acute lymphoblastic leukemia with sequential dose reduced chemotherapy and Blinatumomab
Phase:
II
Contact:
Audrey Tan / Study Nurse
Email-Address:
Audrey.Tan@med.uni-heidelberg.de
Clinical Investigator:
Dr. Simon Raffel
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT03480438
EudraCT-Number:
Siehe EU klinisches Studienregister
2017-002853-13